{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:15:39Z","timestamp":1782515739615,"version":"3.54.5"},"reference-count":37,"publisher":"American Association for Cancer Research (AACR)","issue":"3","funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Cancer Institute","award":["P30 CA15083"],"award-info":[{"award-number":["P30 CA15083"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Nonsteroidal anti-inflammatory agents (NSAID) are associated with modest inconsistent reductions in breast cancer risk in population-based cohorts, whereas two focused studies of patients with benign breast disease (BBD) have found lower risk with NSAID use. Given that BBD includes fibroinflammatory lesions linked to elevated breast cancer risk, we assessed whether NSAID use was associated with lower breast cancer risk among patients with BBD.<\/jats:p>\n                    <jats:p>Participants were postmenopausal women in the Cancer Prevention Study-II (CPS-II), a prospective study of cancer incidence and mortality, who completed follow-up surveys in 1997 with follow-up through June 30, 2015. History of BBD, NSAID use, and covariate data were updated biennially. This analysis included 23,615 patients with BBD and 36,751 patients with non-BBD, including 3,896 incident breast cancers over an average of 12.72 years of follow-up among participants. NSAID use, overall and by formulation, recency, duration, and pills per month was analyzed versus breast cancer risk overall and by BBD status using multivariable-adjusted Cox models; BBD status and NSAID use were modeled as time-dependent exposures.<\/jats:p>\n                    <jats:p>Patients with BBD who reported using NSAIDs experienced lower breast cancer risk (HR, 0.87; 95% CI, 0.78\u20130.97), with similar effects for estrogen receptor (ER)-positive breast cancers [HR, 0.85; 95% confidence interval (CI), 0.74\u20130.97] and ER-negative breast cancers (HR, 0.87; 95% CI, 0.59\u20131.29); among women without BBD, NSAID use was unrelated to risk (HR, 1.02; 95% CI, 0.92\u20131.13; Pinteraction = 0.04). Associations stratified by age, obesity, menopausal hormone use, and cardiovascular disease were similar.<\/jats:p>\n                    <jats:p>Among patients with BBD, NSAID use appears linked to lower breast cancer risk. Further studies to assess the value of NSAID use among patients with BBD are warranted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Prevention Relevance:<\/jats:title>\n                    <jats:p>We examined whether NSAID use, a modifiable exposure, is associated with breast cancer risk in postmenopausal women from the Cancer Prevention Study-II with self-reported benign breast disease, an often inflammatory condition associated with higher rates of breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1940-6207.capr-22-0403","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T21:20:41Z","timestamp":1672780841000},"page":"175-184","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort"],"prefix":"10.1158","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9222-8808","authenticated-orcid":false,"given":"Mark E.","family":"Sherman","sequence":"first","affiliation":[{"name":"1Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6242-5221","authenticated-orcid":false,"given":"Robert A.","family":"Vierkant","sequence":"additional","affiliation":[{"name":"2Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7245-8630","authenticated-orcid":false,"given":"Matthew","family":"Masters","sequence":"additional","affiliation":[{"name":"3Behavioral and Epidemiology Research Program, American Cancer Society, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-8784","authenticated-orcid":false,"given":"Derek C.","family":"Radisky","sequence":"additional","affiliation":[{"name":"4Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8492-9102","authenticated-orcid":false,"given":"Stacey J.","family":"Winham","sequence":"additional","affiliation":[{"name":"2Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2303-4946","authenticated-orcid":false,"given":"Amy C.","family":"Degnim","sequence":"additional","affiliation":[{"name":"5Department of Surgery, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-9322","authenticated-orcid":false,"given":"Celine M.","family":"Vachon","sequence":"additional","affiliation":[{"name":"6Division of Epidemiology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9997-1218","authenticated-orcid":false,"given":"Alpa V.","family":"Patel","sequence":"additional","affiliation":[{"name":"3Behavioral and Epidemiology Research Program, American Cancer Society, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2419-8536","authenticated-orcid":false,"given":"Lauren R.","family":"Teras","sequence":"additional","affiliation":[{"name":"3Behavioral and Epidemiology Research Program, American Cancer Society, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"2025112418233551700_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"key":"2025112418233551700_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrclinonc.2015.8","article-title":"Current management of lesions associated with an increased risk of breast cancer","volume":"12","author":"Morrow","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"2025112418233551700_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1158\/1055-9965.EPI-15-0452","article-title":"Aspirin use and risk of breast cancer: systematic review and meta-analysis of observational studies","volume":"24","author":"Zhong","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025112418233551700_bib4","doi-asserted-by":"crossref","first-page":"690219","DOI":"10.3389\/fonc.2021.690219","article-title":"Aspirin use and common cancer risk: a meta-analysis of cohort studies and randomized controlled trials","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"2025112418233551700_bib5","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1158\/0008-5472.CAN-13-3514","article-title":"Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease","volume":"74","author":"Catsburg","year":"2014","journal-title":"Cancer Res"},{"key":"2025112418233551700_bib6","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1158\/1078-0432.CCR-16-2026","article-title":"Alterations in the immune cell composition in premalignant breast tissue that precede breast cancer development","volume":"23","author":"Degnim","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2025112418233551700_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1940-6207.CAPR-20-0178","article-title":"Breast cancer risk and use of nonsteroidal anti-inflammatory agents after a benign breast biopsy","volume":"13","author":"Sherman","year":"2020","journal-title":"Cancer Prev Res (Phila)"},{"key":"2025112418233551700_bib8","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/cncr.21763","article-title":"Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease","volume":"106","author":"Gallicchio","year":"2006","journal-title":"Cancer"},{"key":"2025112418233551700_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"2025112418233551700_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/1055-9965.EPI-16-0556","article-title":"Systemic levels of estrogens and PGE2 synthesis in relation to postmenopausal breast cancer risk","volume":"26","author":"Kim","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025112418233551700_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1158\/1940-6207.CAPR-13-0040","article-title":"Association between urinary prostaglandin E2 metabolite and breast cancer risk: a prospective, case-cohort study of postmenopausal women","volume":"6","author":"Kim","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"2025112418233551700_bib12","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1158\/1055-9965.EPI-14-0685","article-title":"Urinary prostaglandin E2 metabolite and breast cancer risk","volume":"23","author":"Cui","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025112418233551700_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"key":"2025112418233551700_bib14","doi-asserted-by":"crossref","first-page":"n2521","DOI":"10.1136\/bmj.n2521","article-title":"US taskforce advises against low dose aspirin for primary prevention of cardiovascular disease","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"2025112418233551700_bib15","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jama.2022.3385","article-title":"Aspirin use to prevent cardiovascular disease and colorectal cancer: updated modeling study for the US preventive services task force","volume":"327","author":"Dehmer","year":"2022","journal-title":"JAMA"},{"key":"2025112418233551700_bib16","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.2022.3337","article-title":"Aspirin use to prevent cardiovascular disease and colorectal cancer: updated evidence report and systematic review for the US preventive services task force","volume":"327","author":"Guirguis-Blake","year":"2022","journal-title":"JAMA"},{"key":"2025112418233551700_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/cncr.29766","article-title":"Clinicopathologic features of breast cancers that develop in women with previous benign breast disease","volume":"122","author":"Visscher","year":"2016","journal-title":"Cancer"},{"key":"2025112418233551700_bib18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/1940-6207.CAPR-11-0195","article-title":"Cancer interception","volume":"4","author":"Blackburn","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"2025112418233551700_bib19","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1002\/cncr.101970","article-title":"The american cancer society cancer prevention study II nutrition cohort: rationale, study design, and baseline characteristics","volume":"94","author":"Calle","year":"2002","journal-title":"Cancer."},{"key":"2025112418233551700_bib20","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/jnci\/djj439","article-title":"Age-related lobular involution and risk of breast cancer","volume":"98","author":"Milanese","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2025112418233551700_bib21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/1940-6207.CAPR-20-0216","article-title":"Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: a randomized clinical trial","volume":"13","author":"Drew","year":"2020","journal-title":"Cancer Prev Res (Phila)"},{"key":"2025112418233551700_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1148\/rg.2019180124","article-title":"Calcifications at digital breast tomosynthesis: imaging features and biopsy techniques","volume":"39","author":"Horvat","year":"2019","journal-title":"Radiographics."},{"key":"2025112418233551700_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.seminoncol.2015.09.012","article-title":"Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression","volume":"43","author":"Gucalp","year":"2016","journal-title":"Semin Oncol"},{"key":"2025112418233551700_bib24","volume-title":"Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report","author":"Dahabreh","year":"2014"},{"key":"2025112418233551700_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13058-016-0791-4","article-title":"Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients","volume":"19","author":"Mullooly","year":"2017","journal-title":"Breast Cancer Res"},{"key":"2025112418233551700_bib26","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1158\/1078-0432.CCR-12-2603","article-title":"Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer","volume":"19","author":"Howe","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2025112418233551700_bib27","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1158\/1055-9965.EPI-09-0975","article-title":"Analgesic use and sex steroid hormone concentrations in postmenopausal women","volume":"19","author":"Gates","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025112418233551700_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.soard.2010.05.013","article-title":"Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity","volume":"7","author":"Hardy","year":"2011","journal-title":"Surg Obes Relat Dis"},{"key":"2025112418233551700_bib29","doi-asserted-by":"crossref","first-page":"E506","DOI":"10.1152\/ajpendo.00586.2009","article-title":"Insulin-sensitive obesity","volume":"299","author":"Kloting","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2025112418233551700_bib30","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","author":"Collaborative Group on Hormonal Factors in Breast C","year":"2019","journal-title":"Lancet"},{"key":"2025112418233551700_bib31","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","article-title":"The decrease in breast-cancer incidence in 2003 in the United States","volume":"356","author":"Ravdin","year":"2007","journal-title":"N Engl J Med"},{"key":"2025112418233551700_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jnci\/95.4.302","article-title":"Effects of tamoxifen on benign breast disease in women at high risk for breast cancer","volume":"95","author":"Tan-Chiu","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2025112418233551700_bib33","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1158\/1055-9965.EPI-05-0017","article-title":"Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women","volume":"14","author":"Schairer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025112418233551700_bib34","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer","year":"2012","journal-title":"N Engl J Med"},{"key":"2025112418233551700_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/M15-0971","article-title":"Factors associated with rates of false-positive and false-negative results from digital mammography screening: an analysis of registry data","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann Intern Med"},{"key":"2025112418233551700_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/(SICI)1097-0215(19970502)71:3<333::AID-IJC4>3.0.CO;2-Z","article-title":"Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. WHO collaborative study of neoplasia and steroid contraceptives","volume":"71","author":"Aaman","year":"1997","journal-title":"Int J Cancer"},{"key":"2025112418233551700_bib37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/jnci\/djaa114","article-title":"Effect of aspirin on cancer incidence and mortality in older adults","volume":"113","author":"McNeil","year":"2021","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-22-0403\/3237719\/capr-22-0403.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-22-0403\/3262471\/capr-22-0403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/16\/3\/175\/3271220\/175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/16\/3\/175\/3271220\/175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T23:24:23Z","timestamp":1764026663000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/16\/3\/175\/716696\/Benign-Breast-Disease-NSAIDs-and-Postmenopausal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,1,3]]},"published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-22-0403","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22535284.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22535281","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547816.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22535287","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22535284","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547816","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22535287.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22535281.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1940-6207.30701929","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.30701926","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.30701932","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]}}}